InsidersTradesSigma
Discover the detailed record of transactions filed by Giordano Natasha, Chairman & CEO. Officer active across 1 companies, notably PLx Pharma Inc.. Aggregated, 1 reports have been published. Total volume traded: €14k. The latest transaction was filed on 15 March 2022 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
1 of 1 declaration
Natasha Giordano serves as the Chief Executive Officer of PLx Pharma Inc. She is responsible for the strategic direction of the company, overseeing all operations and business initiatives. With extensive experience in the pharmaceutical industry, she plays a key role in developing new products and expanding markets. Her vision and leadership are crucial for the success of PLx Pharma.